TAMIKA CHESTER: Open Payments
NPI 1053770669 · WARNER ROBINS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,031 in 124 payments from 14 companies in 2025. Trend: 2023 $1,936 · 2024 $6,499 · 2025 $7,031
Speaker / faculty: $4,650Food & beverage: $2,243Education: $138
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $5,149 |
| Regeneron Healthcare Solutions, Inc. | 19 | $545 |
| Janssen Biotech, Inc. | 8 | $306 |
| PFIZER INC. | 15 | $174 |
| GENZYME CORPORATION | 5 | $174 |
| UCB, Inc. | 16 | $143 |
| Incyte Corporation | 9 | $138 |
| Novartis Pharmaceuticals Corporation | 5 | $103 |
| E.R. Squibb & Sons, L.L.C. | 4 | $68 |
| LEO Pharma Inc. | 3 | $63 |
Products named: RINVOQ, SKYRIZI, DUPIXENT, TREMFYA, CIBINQO, Bimzelx, OPZELURA, COSENTYX.
Industry payments across GA — which companies pay providers there.
